The government is working on a covid-19 anti-viral pill according to the NY Times.

  • Share:
  • facebook
  • linkedin
  • twitter
Many of us have already had covid-19 and are perfectly fine, while some are having problems long after the infection. Yes, getting vaccinated markedly reduces your risk, although this approach does have a smaller amount of risk too.    On the other hand, while much safer than having covid, is there another way to get immunity with less risk? When I had Covid-19, my wife gave it to me even though she tested negative a couple of times and it seemed like a cold.   She had been ill for a week and then I was tested positive.   I followed a protocol given to me by a reliable source and was back at work the following week fully recovered.  This all-natural protocol was inexpensive and more importantly, it worked. The U.S. government is spending big $$$ on antiviral pills that can shorten the course and severity of covid-19 and other future infections.   If you recover more quickly with a reduced infection from a virus, you are less likely to have any problem after recovering and you will also have natural immunity as well to future infections. This can be a good policy if it works that can circumvent the next pandemic or epidemic. This sounds like a great strategy.  Check out the article from the NY Times

A Pill to Treat Covid-19? The U.S. Is Betting on It.

A new $3.2 billion program will support the development of antiviral pills, which could start arriving by the end of this year.

by Carl Zimmer Published June 17, 2021 The U.S. government spent more than $18 billion last year funding drugmakers to make a Covid vaccine, an effort that led to at least five highly effective shots in record time. Now it’s pouring more than $3 billion on a neglected area of research: developing pills to fight the virus early in the course of infection, potentially saving many lives in the years to come. The new program, announced on Thursday by the Department of Health and Human Services, will speed up the clinical trials of a few promising drug candidates. If all goes well, some of those first pills could be ready by the end of the year. The Antiviral Program for Pandemics will also support research on entirely new drugs — not just for the coronavirus, but for viruses that could cause future pandemics. Read more